'A landmark moment for the field': FDA approves first-ever gene therapy for inherited deafness - Live Science

This week’s cover of the international journal 'Science' features an illustration combining a human lung with a map of the United States. It indirectly depicts research findings that a gene mutation increasing lung cancer risk is concentrated in the southeastern region of the US. This work identifies a genetic legacy that can be traced back several centuries. An international research team including Harvard Medical School in the United States analyzed genetic and health data from more than 3.3 million people and confirmed that a germline 'EGFR T790M' gene mutation is strongly associated with lung cancer risk. The results were published in Science on the 17th (local time).

The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career guidance, and more. The US Food and Drug Administration’s scientific advisory committees that help the agency make decisions around health policy and other topics are convening far less often.

Senior leaders from Novartis, Eli Lilly, Pfizer, Takeda, Menarini, GSK, AstraZeneca, Novo Nordisk and other global pharmaceutical companies, alongside leading academics, investors, regulators and biotechnology innovators Newly announced highlights include a pharma chief executive panel, an FDA and ARPA-H regulatory discussion, the XPRIZE Healthspan finalists, and dedicated forums on AI drug discovery, pet longevity and virtual aging cells